
1. Indicated for the treatment of Clostridium difficile-associated diarrhea (CDAD) in adult and pediatric patients aged 6 months and older.
2. To reduce the development of drug-resistant bacteria and maintain the effectiveness of fidaxomicin and other antibacterial agents, fidaxomicin should only be used to treat infections that are proven or strongly suspected to be caused by Clostridium difficile.
The recommended dose of fidaxomicin for adult patients is one 200mg fidaxomicin tablet, taken twice daily for 10 consecutive days.
Fidaxomicin is a drug specifically used to fight Clostridium difficile infection. Fidaxomicin interferes...
Fidaxomicin is approved for the treatment of Clostridium difficile-associated diarrhea in adults (18 years and...
Fidaxomycin (DIFICID) is a narrow-spectrum antibiotic that precisely kills pathogens by inhibiting the RNA...
Fidaxomicin is a macrolide antibiotic that fights Clostridium difficile infection by inhibiting bacterial RNA...
Fidaxomicin(DIFICID) is a narrow-spectrum macrolide antibiotic specifically used to treat Clostridium...
Fidaxomicin was officially approved by the U.S. Food and Drug Administration (FDA) on May 27, 2011 and was...